St. James Therapeutics

Overview

Cancer is tough. Treatment shouldn’t be. At St. James Therapeutics, we work to develop novel, yet practical products to help people throughout any stage of their cancer journey.

Funding and backers

Total raised
$350k
1 round on record
Latest round
$350k
Venture round · Aug 2023 · 3 yr ago
The money's age
Long since its last round
39 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 9, 2023 Raised a round Venture round $350k · SEC Form D 2018 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Aug 2023 $350k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity St. James Therapeutics Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Michael AllioExecutive Officer, DirectorSEC Form D
Mark AllioExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Andreessen Horowitz
backs Thyme Care
Hub71
backs whiteboxhr
SOSV
backs VeruStruct
CDP Venture Capital
backs Atempo Growth
AlleyCorp
backs Thyme Care
Foresite Capital
backs Thyme Care
Similar startupsby what they do, their industry and backers
Pulsed GmbHFounded 2022
PULSED strives to develop novel infrared laser technology for science, industry and medicine.
whiteboxhr
People are complex, but deciding who to hire, engage, or retain shouldn’t be. At WhiteBox HR, we provide predictive insights, bias free, at…
Thyme CareVenture round $97M · 19 mo ago · Founded 2020 · 51-200 employees · 1 role
Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes…
Cairn TherapeuticsVenture round $3M · 5 yr ago · Founded 2020 · 51-200 employees
Cairn Therapeutics: Targeting the Cancer, just the cancer. Making cancer treatment simpler and safer with CT-262.
KalvotechVenture round · 2 mo ago · Founded 2023
Founded in 2023, KalvoTech develops novel biomaterials processes and services for biotech innovation.
Atempo Growth11-50 employees
Atempo Growth backs European tech companies by providing growth lending solutions to support them at every stage of their growth.

Financials

Total raised
$350k
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $350k Details

People

Michael Allio
Executive Officer, Director
SEC Form D
Mark Allio
Executive Officer, Director
SEC Form D
Michele Allio
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Akron United States
HQ